Exposure to nicotine during a defined period in neonatal life induces permanent changes in brain nicotinic receptors and in behaviour of adult mice

Brain Research

Volumn 853, Issue 1, 2000, Pages 41-48

  Eriksson, Per ^a   Ankarberg, Emma ^a   Fredriksson, Anders ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Adult; Behavior; Developmental neurotoxicity; Neonatal; Nicotine; Nicotinic receptor

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BINDING SITE; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; LOCOMOTION; MOUSE; NEUROTOXICITY; NEWBORN; NONHUMAN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; REARING; RECEPTOR AFFINITY; RECEPTOR DENSITY;

ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BINDING SITES; BINDING, COMPETITIVE; BODY WEIGHT; BRAIN; DRUG ADMINISTRATION SCHEDULE; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED STRAINS; NICOTINE; RECEPTORS, NICOTINIC; TIME FACTORS;

EID: 0033970598     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)02231-3     Document Type: Article

References (57)

1. Ahlbom J., Fredriksson A., Eriksson P. Neonatal exposure to a type-I pyrethroid (bioallethrin) induces dose-response changes in brain muscarinic receptors and behaviour in neonatal and adult mice. Brain Res. 645:1994;318-324.
2. Ahlbom J., Fredriksson A., Eriksson P. Exposure to an organophosphate (DFP) during a defined period in neonatal life induces permanent changes in brain muscarinic receptors and behaviour in adult mice. Brain Res. 677:1995;13-19.
3. Archer T., Fredriksson A., Lewander T., Söderberg U. Marble burying and spontaneous motor activity in mice: interactions over days and effect of diazepam. Scand. J. Psychol. 28:1987;242-249.
4. Aubert I., Cecyre D., Gauthier S., Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. J. Comp. Neurol. 369:1996;31-35.
5. Bartus R.T., Dean R.L. III, Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
6. Berger F., Gage F.H., Vijayaraghavan S. Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells. J. Neurosci. 18:1998;6871-6881.
7. Birdsall N.J.M., Burgen A.S.V., Hulme E.C. The binding of agonist to brain muscarinic receptors. Mol. Pharmacol. 14:1978;723-736.
8. Bolles R.G., Woods P.J. The ontogeny of behaviour in the albino rat. Anim. Behav. 12:1964;427-441.
9. Campbell B.A., Lytle L.D., Fibiger H.C. Ontogeny of adrenergic arousal and cholinergic inhibitory mechanisms in the rat. Science. 166:1969;635-637.
10. Couturier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Millar N., Valera S., Barkes T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron. 5:1990;847-856.
11. Coyle J.T., Yamamura H.I. Neurochemical aspects of the ontogenesis of cholinergic neurons in the rat brain. Brain Res. 118:1976;429-440.
12. Dahlström A., Lundell B., Curvall M., Thapper L. Nicotine and cotinine concentrations in the nursing mother and her infant. Acta Paediatr. Scand. 79:1990;142-147.
13. A.N. Davison, J. Dobbing, Applied Neurochemistry, Blackwell, Oxford, 1968, pp. 178-221, 253-316.
14. Dominguez-del-Toro E., Juiz J.M., Smillie F.I., Lindstrom J., Criado M. Expression of alpha7 neuronal nicotinic receptors during postnatal development of the rat cerebellum. Dev. Brain Res. 98:1997;125-133.
15. Drachman D.A. Cognitive function in man. Does the cholinergic system have a special role? Neurology. 27:1977;783-790.
16. Eriksson P. Developmental neurotoxicity of environmental agents in the neonate. Neurotoxicology. 18:1997;719-726.
17. Eriksson P., Fredriksson A. Neurotoxic effects of two different pyrethroids, bioallethrin and deltamethrin, on immature and adult mice: changes in behavioral and muscarinic receptor variables. Toxicol. Appl. Pharmacol. 108:1991;78-85.
18. Eriksson P., Fredriksson A. Developmental neurotoxicity of four ortho-substituted polychlorinated biphenyls in the neonatal mouse. Environ. Toxicol. Pharmacol. 1:1996;155-165.
19. Eriksson P., Fredriksson A. Neurotoxic effects in adult mice neonatally exposed to 3,3′,4,4′5-pentachlorobiphenyl or 2,3,3′,4,4′-pentachlorobiphenyl. Changes in brain nicotinic receptors and behaviour. Environ. Toxicol. Pharmacol. 5:1998;17-27.
20. Eriksson P., Nordberg A. The effects of DDT, DDOH-palmitic acid, and a chlorinated paraffin on muscarinic receptors and the sodium-dependent choline uptake in the central nervous system of immature mice. Toxicol. Appl. Pharmacol. 85:1986;121-127.
21. Eriksson P., Ahlbom J., Fredriksson A. Exposure to DDT during a defined period in neonatal life induces permanent changes in brain muscarinic receptors and behaviour in adult mice. Brain Res. 582:1992;277-281.
22. Eriksson P., Johansson U., Ahlbom J., Fredriksson A. Neonatal exposure to DDT induces increased susceptibility to pyrethroid (bioallethrin) exposure at adult age. Changes in cholinergic muscarinic receptor and behavioural variables. Toxicology. 77:1993;21-30.
23. Falkeborn Y., Larsson C., Nordberg A., Slanina P. A comparison of the regional ontogenesis of nicotine- and muscarine-like binding sites in the mouse brain. Int. J. Dev. Neurochem. 1:1983;187-190.
24. Fiedler E.P., Marks M.J., Collins A.C. Postnatal development of cholinergic enzymes and receptors in mouse brain. J. Neurochem. 49:1987;983-990.
25. Flores C.M., Rogers S.W., Pabreza L.A., Wolfe B.B., Kellar K.J. A subtype of nicotinic cholinergic receptor in rat brain is composed of a α4 and β2 subunits and is up-regulated by chronic nicotine teatment. Mol. Pharmacol. 41:1992;31-37.
26. Henningfield J.E., Woodson P.P. Dose related action of nicotine on behaviour and physiology: review and implication for replacement therapy for nicotine dependence. J. Subst. Abuse. 1:1988;301-317.
27. Johansson U., Fredriksson A., Eriksson P. Bioallethrin causes permanent changes in behavioural and cholinergic muscarinic receptor variables in adult mice exposed neonatally to DDT. Eur. J. Pharmacol. 293:1995;159-166.
28. Johansson U., Fredriksson A., Eriksson P. Low-dose effects of paraoxon in adult mice exposed neonatally to DDT: changes in behavioural and cholinergic receptor variables. Environ. Toxicol. Pharmacol. 2:1996;307-314.
29. A.G. Karczmar, Cholinergic influences on behaviour, in: P.G. Waser (Ed.), Cholinergic Mechanisms, Raven Press, New York, 1975, pp. 501-529.
30. R.E. Kirk, Experimental design, Procedures for Behavioural Sciences, Brooks/Cole, Belmont, CA, 1968.
31. Kolb B., Whishaw I.Q. Plasticity in the neocortex: mechanisms underlying recovery from early brain damage. Prog. Neurobiol. 32:1989;235-276.
32. Kuhar M.J., Birdsall N.J.M., Burgen A.S.V., Hulme E.C. Ontogeny of muscarinic receptors in rat brain. Brain Res. 184:1980;375-383.
33. Levin E.D., Wilkerson A., Jones J.P., Christopher N.C., Briggs S.J. Prenatal nicotine effects on memory in rats: pharmacological and behavioural challenges. Dev. Brain Res. 97:1996;207-215.
34. Liu C., Nordberg A., Zhang X. Differential co-expression of nicotinic acetylcholine receptor α4 and β2 subunit genes in various regions of rat brain. NeuroReport. 7:1996;1645-1649.
35. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
36. Marks M.J., Pauly J.R., Gross S.D., Deneris E.S., Hermans-Borgmeyer I., Heinemann S.F., Collins A.C. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J. Neurosci. 12:1992;2765-2784.
37. McFarland B.J., Seidler F.J., Slotkin T.A. Inhibition of DNA synthesis in the neonatal rat brain regions caused by acute nicotine administration. Dev. Brain Res. 58:1991;223-229.
38. Miao H., Liu C., Bishop K., Gong Z.H., Nordberg A., Zhang X. Nicotine exposure during a critical period of development leads to persistent changes in nicotinic acetylcholine receptors of adult rat brain. J. Neurochem. 70:1998;752-762.
39. Miner L.L., Collins A.C. Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol. Biochem. Behav. 33:1989;469-475.
40. Munson P.J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding system. Anal. Biochem. 107:1980;220-239.
41. Nordberg A. Neuronal nicotinic receptors and their implications in ageing and neurodegenerative disorders in mammals. J. Reprod. Fertil. Suppl. 46:1993;145-154.
42. Nordberg A., Adem A., Hardy J. Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains. Neurosci. Lett. 86:1988;317-321.
43. Nordberg A., Zhang X., Fredriksson A., Eriksson P. Neonatal nicotine exposure induces permanent changes in brain nicotinic receptors and behaviour in adult mice. Dev. Brain Res. 63:1991;201-207.
44. Orr-Urtreger A., Goldner F.M., Saeki M., Lorenzo I., Goldberg L., De-Biasi M., Dani J.A., Patrick J.W., Beaudet A.L. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotine currents. J. Neurosci. 17:1997;9165-9171.
45. Samuel N., Wonnacott S., Lindstrom J., Futerman A.H. Parallel increases in [alpha-125I]bungarotoxin binding and alpha 7 nicotinic subunit immunoreactivity during the development of rat hippocampal neurons in culture. Neurosci. Lett. 222:1997;179-182.
46. Shacka J.J., Robinson S.E. Exposure to prenatal nicotine transiently increases neuronal nicotinic receptor subunit alpha7, alpha4 and beta2 messenger RNAs in the postnatal brain. Neuroscience. 84:1998;1151-1161.
47. Slotkin T.A. Fetal nicotine or cocaine exposure: Which one is worse. J. Pharmacol. Exp. Ther. 285:1998;931-945.
48. Slotkin T.A., Lappi S.E., Seidler F.J. Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal. Brain Res. Bull. 31:1993;319-328.
49. 3H ]nicotine binding sites in brain J. Pharmacol. Exp. Ther. 233:1987;361-368.
50. J.A. Stitzel, S.F. Robinson, M.J. Marks, A.C. Collins, Differences in the response to nicotine are determined by genetic factors, Adv. Pharmacol. Sci. (1997) 279-284.
51. Talts U., Fredriksson A., Eriksson P. Changes in behaviour and muscarinic receptor density after neonatal and adult exposure to bioallethrin. Neurobiol. Aging. 19:1998;545-552.
52. Talts U., Talts J., Eriksson P. Differential expression of muscarinic subtype mRNAs after exposure to neurotoxic pesticides. Neurobiol. Aging. 19:1998;553-559.
53. Tizabi Y., Popke E.J., Rahman M.A., Nespor S.M., Grunberg N.E. Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors. Pharmacol. Biochem. Behav. 58:1997;141-146.
54. Whiting P.J., Lindstrom J.M. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J. Neurosci. 8:1988;3395-3404.
55. Winzer-Serhan U.H., Leslie F.M. Codistribution of nicotine acetylcholine receptor subunit alpha3 and beta4 mRNAs during rat brain development. J. Comp. Neurol. 386:1997;540-554.
56. Wonnacott S. α-Bungarotoxin binds to low-affinity nicotine binding sites in rat brain. J. Neurochem. 47:1986;1706-1712.
57. Zhang X., Wahlström G., Nordberg A. Influence of development and aging on nicotinic receptor subtypes in rodent brain. Int. J. Dev. Neurosci. 8:1990;715-721.